Autoantibodies against cytoskeletal neuronal proteins in sera of arsenic-exposed subjects correlate with neurological symptoms

References

• Abou-Donia, M.B. 1981. “Organophosphorus Ester-Induced Delayed Neurotoxicity.” Annual Review of Pharmacology and Toxicology 21: 511–548.
   PubMed Web of Science ®Google Scholar
• Abou-Donia, M.B. 1993. “The Cytoskeleton As a Target for Organophosphorus Ester-Induced Delayed Neurotoxicity (OPIDN).” Chemico-Biological Interactions 87: 383–393.
   PubMed Web of Science ®Google Scholar
• Abou-Donia, M.B. 1995. “Involvement of Cytoskeletal Proteins in the Mechanisms of Organophosphorus Ester-Induced Delayed Neurotoxicity.” Clinical and Experimental Pharmacology and Physiology 22: 358–359.
   PubMed Web of Science ®Google Scholar
• Abou-Donia, M.B. 2003. “Organophosphorus Ester-Induced Chronic Neurotoxicity.” Archives of Environmental Health 58: 484–497.
   PubMed Web of Science ®Google Scholar
• Abou-Donia, M.B., M.M. Abou-Donia, E.M. ElMasry, J.A. Monro, and M.F.A. Mulder. 2013. “Autoantibodies to Nervous System-Specific Proteins are Elevated in Sera of Flight Crew Members: Biomarkers for Nervous System Injury.” Journal of Toxicology and Environmental Health A 76: 363–380.
   PubMedGoogle Scholar
• Abou-Donia, M.B., and L.K. Garretson. 2000. “Detection of Neurofilament Autoantibodies in Human Serum Following Chemically Induced Neurologic Disorder: A Case Report.” Environmental Epidemiology and Toxicology 2: 1–5.
   Google Scholar
• Abou-Donia, M.B., and D.M. Lapadula. 1990. “Mechanisms of Organophosphorus Ester-Induced Delayed Neurotoxicity: Type I and Type II.” Annual Review of Pharmacology and Toxicology 30: 405–550.
   PubMed Web of Science ®Google Scholar
• Abou-Donia, M.B., M. Viana, R.P. Gupta, and J. Knoth-Anderson. 1993. “Enhanced Calmodulin Binding Concurrent With Increased Kinase-Dependent Phosphorylation of Cytoskeletal Proteins Following a Single Subcutaneous Injection of Diisopropyl Phosphorofluoridate (DFP) in Hens.” Neurochemistry International 22: 165–173.
   PubMed Web of Science ®Google Scholar
• Ahmad, S.A., M.H.S.U. Sayed, and S. Barua. 2001. “Arsenic in Drinking Water and Pregnancy Outcomes.” Environmental Health Perspectives 109: 629–631.
   PubMed Web of Science ®Google Scholar
• Bernstam, L., and J. Nriagu. 2000. “Molecular Aspects of Arsenic Stress.” Journal of Toxicology and Environmental Health B 3: 293–322.
   PubMed Web of Science ®Google Scholar
• Bolla-Wilson, K., and M.L. Bleecker 1987. “Neuropsychological Impairment Following Inorganic Arsenic Exposure.” Journal of Occupational and Environmental Medicine 29: 500–503.
   Web of Science ®Google Scholar
• Cardenas, A.M., A.O. Ardiles, N. Barraza, X. Baez-Matus, and P. Caviedes. 2012. “Role of Tau Protein in Neuronal Damage in Alzheimer's Disease and Down's Syndrome.” Archives of Medical Research 43: 645–654.
   PubMed Web of Science ®Google Scholar
• Chen, Y., J.H. Graziano, F. Parvez, M. Liu, V. Slavkovich, T. Kalra, M. Argos, et al. 2011. “Arsenic Exposure from Drinking Water and Mortality from Cardiovascular Disease in Bangladesh: Prospective Cohort Study.” British Medical Journal 342: d2431.
   PubMed Web of Science ®Google Scholar
• Dadwhal, M., M. Sahimi, and T.T. Tsotsis. 2011. “Adsorption Isotherms of Arsenic on Conditioned Layered Double Hydroxides in the Presence of Various Competing Ions.” Industrial & Engineering Chemistry Research 50: 2220–2226.
   Web of Science ®Google Scholar
• Ehrich, M., and B.S. Jortner. 2001. Organophosphate-Induced Delayed Neuropathy, Handbook of Neurotoxicology. Vol. 1. New York: Humana Press, pp. 17–27.
   Google Scholar
• El-Fawal, H.A., Z. Gong, A.R. Little, H.L. Evans. 1996. “Exposure to Methyl Mercury Results in Serum Autoantibodies to Neurotypic and Gliotypic Proteins.” Neurotoxicology 17: 531–539.
   PubMed Web of Science ®Google Scholar
• El-Fawal, H.A., and W.C. McCain. 2008. “Antibodies to Neural Proteins in Organophosphorus-Induced Delayed Neuropathy (OPIDN) and Its Amelioration.” Neurotoxicology and Teratology 30: 161–166.
   PubMed Web of Science ®Google Scholar
• Flanagan, S.V., R.B. Johnston, and Y. Zheng. 2012. “Arsenic in Tube Well Water in Bangladesh: Health and Economic Impacts and Implications for Arsenic Mitigation.” Bulletin of the World Health Organization 90: 839–846.
   PubMed Web of Science ®Google Scholar
• Hall, A.H. 2002. “Chronic Arsenic Poisoning.” Toxicology Letters 128: 69–72.
   PubMed Web of Science ®Google Scholar
• Jiang, J.Q., S.M. Ashekuzzaman, A. Jiang, S.M. Sharifuzzaman, and S.R. Chowdhury. 2012. “Arsenic Contaminated Groundwater and its Treatment Options in Bangladesh.” International Journal of Environmental Research and Public Health 10: 18–46.
   PubMed Web of Science ®Google Scholar
• Julien, J.P. 1999. “Neurofilament Functions in Health and Disease.” Current Opinion in Neurobiology 9: 554–560.
   PubMed Web of Science ®Google Scholar
• Khan, M.M., F. Sakauchi, T. Sonoda, M. Washio, and M. Mori. 2003. “Magnitude of Arsenic Toxicity in Tube-Well Drinking Water in Bangladesh and its Adverse Effects on Human Health Including Cancer: Evidence From a Review of the Literature.” Asian Pacific Journal of Cancer Prevention 4: 7–14.
   PubMedGoogle Scholar
• Lin, T.-H., Y.-L. Huang, and M.-Y. Wang. 1998. “Arsenic Species in Drinking Water, Hair, Fingernails and Urine of Patients With Blackfoot Disease.” Journal of Toxicology and Environmental Health A 53: 85–93.
   PubMed Web of Science ®Google Scholar
• Luo, J.H., Z.Q. Qiu, L. Zhang, and W.Q. Shu. 2012. “Arsenite Exposure Altered the Expression of NMDA Receptor and Postsynaptic Signaling Proteins in Rat Hippocampus.” Toxicology Letters 211: 39–44.
   PubMed Web of Science ®Google Scholar
• McConnell, R., E. Delgado-Tellez, R. Cuadra, E. Torres, M. Keifer, J. Almendaraz, J. Miranda, et al. 1999. “Organophosphate Neuropathy Due to Metamidophos: Biochemical and Neurophysiologic Markers.” Archives of Toxicology 73: 296–300.
   PubMed Web of Science ®Google Scholar
• Orloff, K., K. Mistry, and S. Metcalf. 2009. “Biomonitoring for Environmental Exposures to Arsenic.” Journal of Toxicology and Environmental Health B 12: 509–524.
   PubMed Web of Science ®Google Scholar
• Pastori, C., M.C. Regondi, L. Librizzi, and M. de Curtis. 2007. “Early Excitability Changes in a Novel Acute Model of Transient Focal Ischemia and Reperfusion in the in Vitro Isolated Guinea Pig Brain.” Experimental Neurology 204: 95–105.
   PubMed Web of Science ®Google Scholar
• Rahman, A., K.M. Khan, G. Al-Khaledi, I. Khan, and S. Attur. 2012. “Early Postnatal Lead Exposure Induces Tau Phosphorylation in the Brain of Young Rats.” Acta Biologica Hungarica 63: 411–425.
   PubMed Web of Science ®Google Scholar
• RamaRao, G., J.N. Acharya, and B.K. Bhattacharya. 2011. “Changes of Protein Oxidation, Calpain and Cytoskeletal Proteins (Alpha Tubulin and pNF-H) Levels in Rat Brain After Nerve Agent Poisoning.” Toxicology Letters 203: 227–236.
   PubMed Web of Science ®Google Scholar
• Reddy, P.H. 2011. “Abnormal Tau, Mitochondrial Dysfunction, Impaired Axonal Transport of Mitochondria, and Synaptic Deprivation in Alzheimer's Disease.” Brain Research 1415: 136–148.
   PubMed Web of Science ®Google Scholar
• Saatman, K.E., K.J. Feeko, R.L. Pape, and R. Raghupathi. 2006. “Differential Behavioral and Histopathological Responses to Graded Cortical Impact Injury in Mice.” Journal of Neurotrauma 23: 1241–1253.
   PubMed Web of Science ®Google Scholar
• Scott, D., K.E. Smith, B.J. O’Brien, and K.J. Angelides. 1985. “Characterization of Mammalian Neurofilament Triplet Proteins: Subunit Stoichiometry and Morphology of Native and Reconstituted Filaments.” Journal of Biological Chemistry 260: 10736–10747.
   PubMed Web of Science ®Google Scholar
• Shepherd, G.M. 1994. “Neuron and Glia.” In Neurobiology, edited by G.M. Shepherd, 36–64. New York: Oxford University Press.
   Google Scholar
• Sheppard, O., F. Plattner, A. Rubin, A. Slender, J.M. Linehan, S. Brandner, V.L. Tybulewicz, et al. 2012. “Altered Regulation of Tau Phosphorylation in a Mouse Model of Down Syndrome Aging.” Neurobiology of Aging 33: e31–e44.
   PubMedGoogle Scholar
• Syed, E.H., K.C. Poudel, K. Sakisaka, J. Yasuoka, H. Ahsan, and M. Jimba. 2012. “Quality of Life and Mental Health Status of Arsenic-Affected Subjects in a Bangladeshi Population.” The Journal of Health, Population and Nutrition 30: 262–269.
   PubMed Web of Science ®Google Scholar
• Tagliaferro, P., A.J. Ramos, E.S. Onaivi, S.G. Evrard, J. Lujilde, and A. Brusco. 2005. “Neuronal Cytoskeleton and Synaptic Densities are Altered After a Chronic Treatment with Cannabinoid Receptor Agonist WIN 55, 212–2.” Brain Research 1085: 163–176.
   Web of Science ®Google Scholar
• Tsai, S.-M., T.-N. Wang, and Y.-C. Ko. 1998. “Cancer Mortality Trends in a Blackfoot Disease Endemic Community of Taiwan Following Water Source Replacement.” Journal of Toxicology and Environmental Health A 55: 389–404.
   PubMed Web of Science ®Google Scholar
• Vahidnia, A., G.B. van der Voet, and F.A. de Wolff. 2007. “Arsenic Neurotoxicity – A Review.” Human & Experimental Toxicology 26: 823–832.
   PubMed Web of Science ®Google Scholar
• Wang, Y., F. Zhao, Y. Liao, Y. Jin, and G. Sun. 2013. “Effects of Arsenite in Astrocytes on Neuronal Signaling Transduction.” Toxicology 303: 43–53.
   PubMed Web of Science ®Google Scholar
• Zurek, J., and M. Fedora. 2011. “Dynamics of Glial Fibrillary Acidic Protein During Traumatic Brain Injury in Children.” Journal of Trauma 71: 854–859.
   PubMed Web of Science ®Google Scholar